API
< Back to all clusters
[BUSINESS] · Morocco, Germany, Belgium · 2 sources

started · updated

Moroccan companies Sothema and OCP announce major acquisition plans

Moroccan companies Sothema and OCP Group have initiated processes to expand their industrial footprints through significant acquisitions.

Sothema, a Casablanca-listed pharmaceutical laboratory, has officially notified the Competition Council of its plan to acquire 100% of the capital and voting rights of Ramo Pharm. Ramo Pharm, based in Casablanca, specializes in the design and marketing of dietary supplements. If approved, the transaction will allow Sothema to expand its operations beyond generic and biosimilar medicines into the dietary supplement market.

Separately, OCP Group intends to take full control of Euro Maroc Phosphore (EMAPHOS), located in Jorf Lasfar. The group plans to acquire the remaining stakes held by its European partners, Germany-based Budenheim and Belgium-based Prayon, through its subsidiary OCP SPS SA. Currently, ownership is split equally at 33.33% among the three partners. The acquisition aims to consolidate OCP’s control over the production of high-purity phosphoric acid, which serves the food, pharmaceutical, and energy transition industries.

Entities

EMAPHOS · Morocco · OCP Group · Ramo Pharm · Sothema